Rutger and Starfish have donated some autographed items to Jake of the U.S.-based organization 'DiscussingFilm'.
These items will be used by 'DiscussingFilm' for a charity raffle to be held around late November that is aimed at comic book and film fans to help raise money for 'The Hispanic Federation Hurricane Relief Fund', based in Puerto Rico.
The devastation caused by Hurricane Maria in Puerto Rico is unprecedented in the island’s modern history and all proceeds from this raffle will help hurricane victims as well as recovery efforts in Puerto Rico.
Sunday, July 19, 2015.
Sarah J. Murray, a long-long-time Starfish's supporter, has joined Starfish's Board of Advisors/Scientific Committee.
She brings to the Board a wide and multi-faceted expertise in Chemical Research and in Science Communication.
Rutger at the Zeitgeist Media Festival
Sunday, August 5, 2012.
Rutger speaks about AIDS at the Zeitgeist Media Festival at Hollywood's Avalon Hotel.
Zeitgeist Media Festival joins a synchronized network of socially conscious events going on globally, uniting the world in collective social consciousness.
Rutger and his organization are working at International Agencies and Governments levels to have AIDS treated as a 'Slow Onset Disaster'.
More information about this initiative can be found on this page.
are pleased to announce that Starfish, in its
efforts to help HIV-stricken children and pregnant
women, now can count on a Scientific Committee/Board of Advisors.
Its first member is Dr. Franco
Lori. Dr. Loris professional experience
includes many different areas within the biotechnology
industry. He is the Founder of Georgetown Universitys
RIGHT (Research Institute for Genetic and Human
Therapy) Institute and has extensive experience
in research, virology and medicine.
Lori discovered that hydroxyurea can inhibit the
growth of HIV and designed pilot clinic studies
to prove its efficacy. Presently, Dr. Lori and
his medical staff are entering a major human trials
phase of their topical DNA vaccine called "DermaVir"
. This therapeutic vaccine for patients
already infected with HIV is applied as a skin
patch. This patch is impregnated with a sugar
solution containing HIV genetic material. Hair-thin
needles underneath penetrate the skin and transport
the vaccine to where it can do its work of suppressing
the further development of chronic viral infections
by reducing their viral load. This vaccine induces
T-cell immunity and has proved to be very successful
on tests performed on monkeys. In August, DermaVir
has been elected "Molecule of the
Month" by the 2002 FDA Science Forum.
Lori and his staff are donating their time and
skills to be of any possible assistance to Starfish
with focused interventions, by giving advice,
guidelines, suggestions and know-how contacts
in all the HIV/AIDS-related areas where this help
is utmostly deemed necessary.